Thermo Fisher Scientific Inc
TMO: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$833.00 | Pzz | Trjlxwdyhc |
Thermo Fisher's Core Business Excels in 2Q: COVID-19 and China Revenue Also Surprise Positively
Wide-moat Thermo Fisher Scientific delivered another robust quarter, driven by strength in its core business, better than expected performance in China, and resilient COVID-19 testing revenue that is not falling off as fast as we anticipated. We're modestly raising our fair value estimate to $590 per share. Shares are fairly valued